MARIO FERNANDEZ FRAGA-rekin lankidetzan egindako argitalpenak (9)

2023

  1. CRISPR/dCAS9-mediated DNA demethylation screen identifies functional epigenetic determinants of colorectal cancer

    Clinical Epigenetics, Vol. 15, Núm. 1

2021

  1. Integrative methylome-transcriptome analysis unravels cancer cell vulnerabilities in infant MLLrearranged B cell acute lymphoblastic leukemia

    Journal of Clinical Investigation, Vol. 131, Núm. 13

2020

  1. No genome-wide DNA methylation changes found associated with medium-term reduced graphene oxide exposure in human lung epithelial cells

    Epigenetics, Vol. 15, Núm. 3, pp. 283-293

2015

  1. Nuclear DICKKOPF-1 as a biomarker of chemoresistance and poor clinical outcome in colorectal cancer

    Oncotarget, Vol. 6, Núm. 8, pp. 5903-5917

2013

  1. Immune-dependent and independent antitumor activity of GM-CSF aberrantly expressed by mouse and human colorectal tumors

    Cancer Research, Vol. 73, Núm. 1, pp. 395-405

  2. Prelamin A causes progeria through cell-extrinsic mechanisms and prevents cancer invasion

    Nature Communications, Vol. 4

2010

  1. Epigenetic repression of ROR2 has a Wnt-mediated, pro-tumourigenic role in colon cancer

    Molecular Cancer, Vol. 9

  2. Nuclear envelope alterations generate an aging-like epigenetic pattern in mice deficient in Zmpste24 metalloprotease

    Aging Cell, Vol. 9, Núm. 6, pp. 947-957

2009

  1. The ADAMTS12 metalloprotease gene is epigenetically silenced in tumor cells and transcriptionally activated in the stroma during progression of colon cancer

    Journal of Cell Science, Vol. 122, Núm. 16, pp. 2906-2913